title: Realigning incentives for developing and pricing new anticancer treatments.
authors.affiliation: Department of Health Policy and Management, Emory University, Atlanta, Georgia 30322, USA. david.howard@emory.edu
authors.forename: David H
authors.initials: DH
authors.lastname: Howard
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D014487:Centers for Medicare and Medicaid Services, U.S.; D003363:Cost Control; D017047:Cost Sharing; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000639:trends*; D055808:Drug Discovery / Q000191:economics*; D004345:Drug Industry; D017048:Health Care Costs / Q000639:trends; D006801:Humans; D008297:Male; D006278:Medicare / Q000191:economics*; D018803:Models, Economic; D009042:Motivation; D058991:Patient Protection and Affordable Care Act; D011471:Prostatic Neoplasms / Q000188:drug therapy; D014481:United States
chemical_list: D000970:Antineoplastic Agents